Unconventional Uses of Common Conventional Drugs: A Review

Overview

Journal Indian J Dermatol Venereol Leprol

Specialties Dermatology
Infectious Diseases
Tropical Medicine

Date 2021 Apr 19

PMID 33871199

Authors

Anupam Das

Abheek Sil

Shouvik Ghosh

Saumya Panda

Affiliations

Soon will be listed here.

References

Mimura M, Hirota S, Sugaya N, Sanches Jr J, Migliari D . Systemic treatment in severe cases of recurrent aphthous stomatitis: an open trial. Clinics (Sao Paulo). 2009; 64(3):193-8. PMC: 2666466. DOI: 10.1590/s1807-59322009000300008. View

Nystrom A, Thriene K, Mittapalli V, Kern J, Kiritsi D, Dengjel J . Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms. EMBO Mol Med. 2015; 7(9):1211-28. PMC: 4568953. DOI: 10.15252/emmm.201505061. View

Akhurst R, Hata A . Targeting the TGFβ signalling pathway in disease. Nat Rev Drug Discov. 2012; 11(10):790-811. PMC: 3520610. DOI: 10.1038/nrd3810. View

Dasgeb B, Kornreich D, McGuinn K, Okon L, Brownell I, Sackett D . Colchicine: an ancient drug with novel applications. Br J Dermatol. 2017; 178(2):350-356. PMC: 5812812. DOI: 10.1111/bjd.15896. View

Raderer M, Muller C, Scheithauer W . Ondansetron for pruritus due to cholestasis. N Engl J Med. 1994; 330(21):1540. DOI: 10.1056/NEJM199405263302117. View

ODonohue J, Pereira S, Ashdown A, Haigh C, Wilkinson J, Williams R . A controlled trial of ondansetron in the pruritus of cholestasis. Aliment Pharmacol Ther. 2005; 21(8):1041-5. DOI: 10.1111/j.1365-2036.2005.02430.x. View

Noguera-Morel L, Gerlero P, Torrelo A, Hernandez-Martin A . Ivermectin therapy for papulopustular rosacea and periorificial dermatitis in children: A series of 15 cases. J Am Acad Dermatol. 2017; 76(3):567-570. DOI: 10.1016/j.jaad.2016.10.034. View

Voelter-Mahlknecht S, Benez A, Metzger S, Fierlbeck G . Treatment of subcutaneous sarcoidosis with allopurinol. Arch Dermatol. 1999; 135(12):1560-1. DOI: 10.1001/archderm.135.12.1560. View

Reisberger E, Landthaler M, Wiest L, Schroder J, Stolz W . Foreign body granulomas caused by polymethylmethacrylate microspheres: successful treatment with allopurinol. Arch Dermatol. 2003; 139(1):17-20. DOI: 10.1001/archderm.139.1.17. View

10.

Mizuno K, Okamoto H, Horio T . Inhibitory influences of xanthine oxidase inhibitor and angiotensin I-converting enzyme inhibitor on multinucleated giant cell formation from monocytes by downregulation of adhesion molecules and purinergic receptors. Br J Dermatol. 2004; 150(2):205-10. DOI: 10.1111/j.1365-2133.2004.05768.x. View

11.

Sapadin A, Fleischmajer R . Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol. 2006; 54(2):258-65. DOI: 10.1016/j.jaad.2005.10.004. View

12.

Monk E, Shalita A, Siegel D . Clinical applications of non-antimicrobial tetracyclines in dermatology. Pharmacol Res. 2010; 63(2):130-45. DOI: 10.1016/j.phrs.2010.10.007. View

13.

Esterly N, Koransky J, Furey N, Trevisan M . Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy. Arch Dermatol. 1984; 120(10):1308-13. View

14.

Wilkin J . Rosacea. Pathophysiology and treatment. Arch Dermatol. 1994; 130(3):359-62. DOI: 10.1001/archderm.130.3.359. View

15.

Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret L . The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol. 2001; 137(1):69-73. DOI: 10.1001/archderm.137.1.69. View

16.

Dezube B, Krown S, Lee J, Bauer K, Aboulafia D . Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study. J Clin Oncol. 2006; 24(9):1389-94. DOI: 10.1200/JCO.2005.04.2614. View

17.

Melchert M, List A . The thalidomide saga. Int J Biochem Cell Biol. 2007; 39(7-8):1489-99. DOI: 10.1016/j.biocel.2007.01.022. View

18.

Wu J, Huang D, Pang K, Hsu S, Tyring S . Thalidomide: dermatological indications, mechanisms of action and side-effects. Br J Dermatol. 2005; 153(2):254-73. DOI: 10.1111/j.1365-2133.2005.06747.x. View

19.

Mascaro J, Lecha M, Torras H . Thalidomide in the treatment of recurrent, necrotic, and giant mucocutaneous aphthae and aphthosis. Arch Dermatol. 1979; 115(5):636-7. View

20.

Saylan T, Saltik I . Thalidomide in the treatment of Behçet's syndrome. Arch Dermatol. 1982; 118(8):536. View